Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal Indomethacin Plus Aggressive Hydration for Post-ERCP Pancreatitis Prophylaxis
NCT07599605Phase 3Completed
- Sponsor
- Hospital General de Chihuahua - Dr. Salvador Zubirán Anchondo
- Start
- Mar 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of indomethacin in pancreatitis, sponsored by Hospital General de Chihuahua - Dr. Salvador Zubirán Anchondo. Started Mar 2024; status: completed.
02
Drugs
indomethacin
03
Conditions
pancreatitis
Beyond the preview
Go deeper on NCT07599605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07599605.